Protein C activity

Company	Reagent	Link to information	Remarks
BioMedica Diagnostics	ACTICLOT C		Method: Clotting Activator: Derived from the venom of the viper agkistrodon contortrix
Chromogenix	Coamatic Protein C		Method: Chromogenic Activator: Derived from the venom of the viper agkistrodon contortrix Interferences: No interference of heparin levels up tot 3 IU/ml
Helena Biosciences	Protein C		Method: Chromogenic Activator: Derived from the venom of the viper agkistrodon contortrix
Hyphen BioMed	Biophen Protein C LRT	Hyphen Biophen Protein C LRT	Method: Chromogenic Activator: Derived from the venom of the viper agkistrodon contortrix Interferences: No interference for heparin < 1 IU/mL, bilirubin < 60 mg/dL, hemoglobin < 500 mg/dL and intralipids concentration < 1000 mg/dL. Aprotinin or presence of anti-human Protein C antibodies may decrease the measured Protein C activity.
Hyphen BioMed	Biophen Protein C	Hyphen Biophen Protein C 5	Method: Chromogenic Activator: Derived from the venom of the viper agkistrodon contortrix Interferences: No interference for heparin < 1 IU/mL, bilirubin < 60 mg/dL, hemoglobin < 500 mg/dL and intralipids concentration < 1000 mg/dL. Aprotinin or presence of anti-human Protein C antibodies may decrease the measured Protein C activity.
Hyphen BioMed	Hemoclot Protein C	Hyphen Hemoclot Protein C	Method: Clotting Activator: Derived from the venom of the viper agkistrodon contortrix Interferences: No interference for heparin < 1 IU/mL. Special caution should be taken for patients with known high levels of FVIII:C or with LA
Nordic Biomarker	MRX Protein C		Method: Chromogenic Activator: Protein C activator Interferences: No interference from heparin < 2 U/ml, bilirubin ≤20 mg/dL, haemoglobin ≤200 mg/dL, triglycerides ≤350 mg/dL
Pentapharm	Protac	Protac	Method: Chromogenic and clotting Activator: Derived from the venom of the viper agkistrodon contortrix
Precision Biologic	Cryocheck Clot C	Precision Biologic Cryocheck Clot C	Method: Clotting Activator: Russell’s viper venom (RVV-X) Interferences: No interference of factor VIII:C activity levels < 600% and heterozygous factor V_Leiden mutation
Renam	Reachrom protein C		Method: Chromogenic
Roche	Protein C Chrom	Roche Protein C Chrom	Method: Chromogenic Activator: Snake venom
Siemens Healthineers	Berichrom Protein C	Siemens Berichrom Protein C	Method: Chromogenic Activator: Derived from the venom of the viper agkistrodon contortrix Interferences: False low protein C activity may be obtained in patients being treated with aprotinin
Siemens Healthineers	Protein C Reagent	Siemens Protein C Reagent	Method: Clotting Activator: Derived from the venom of the viper agkistrodon contortrix Interferences: False low protein C activity may be obtained in patients being treated with aprotinin.
Stago	STA_Stachrom Protein C	Stago STA Stacrom Protein C	Method: Chromogenic Activator: Derived from the venom of the viper agkistrodon contortrix Interferences: No interference from hemoglobin < 2 g/l, bilirubin < 200 mg/l and triglycerides < 4 g/l.
Stago	STA-Staclot Protein C	Stago STA-Staclot Protein C	Method: Clotting Activator: Derived from the venom of the viper agkistrodon contortrix Interferences: No interference from heparin < 1 U/ml, LA, factor VIII:C activity levels < 250%. Trombin inhibitors may interference
Stago, Tcoag	TriniCLOT Protein C II	Stago TriniCLOT Protein C II	Method: Clotting Activator: Derived from the venom of the viper agkistrodon contortrix
Technoclone	Technochrom Protein C	Technoclone Technochrom Protein C	Method: Chromogenic Activator: Derived from the venom of the viper agkistrodon contortrix Interferences: No interference from heparin < 2 U/ml
Technoclone	Technoclot Protein C	Technoclone Technoclot Protein C	Method: Clotting Activator: Derived from the venom of the viper agkistrodon contortrix
Werfen	HemosIL Proclot	Werfen HemosIL ProClot	Method: Clotting Activator: Derived from the venom of the viper agkistrodon contortrix Interferences: No interference from heparin (LMW) up to 0.7 U/mL, heparin (UF) up to 1.5 U/mL, hemoglobin < 200 mg/dL, bilirubin < 25 mg/dL and triglycerides < 600 mg/dL. Protein C results may be affected by LA and high levels of factor VIII (>250%) and APC-R
Werfen	HemosIL Protein C	Werfen HemosIL Protein C	Method: Chromogenic Activator: Derived from the venom of the viper agkistrodon contortrix Interferences: no interference from heparin (UF or LMW heparin) < 2 U/mL, hemoglobin < 200/500 mg/dL, triglycerides < 500/890 mg/dL and bilirubin 5/ 21 mg/dL. ACL Classic/ACL TOP.

ECAT

Protein C activity

ECAT Foundation

Direct links

Contact

Newsletter